HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could early antibiotic stop be safe for kids with cancer?
Disease control Not yet recruitingThis trial looks at whether children with cancer who develop a fever and low white blood cells can safely stop antibiotics earlier than usual. About 136 children will be randomly assigned to either stop antibiotics within 24 hours or continue standard treatment. The goal is to se…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE4 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug may cut transfusions for stem cell transplant patients
Disease control Not yet recruitingThis study tests if luspatercept can help people with blood cancers who have severe anemia after a stem cell transplant. The goal is to see if the drug reduces the need for red blood cell transfusions. About 20 adults aged 18-60 will take part. This is a phase 2 trial, meaning it…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Cord blood hope for elderly blood cancer patients
Disease control Not yet recruitingThis study tests a special chemotherapy combination followed by a single umbilical cord blood transplant in 44 patients aged 60-69 with blood cancers. The goal is to see if this approach is safe and reduces the risk of cancer returning within 180 days. Participants receive severa…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Off-the-Shelf cell therapy takes aim at tough blood cancers
Disease control Not yet recruitingThis early study tests a new treatment for people with B-cell blood cancers that have come back or not responded to standard therapy. The treatment uses donor immune cells (CAR-T cells) designed to find and attack cancer cells. The main goal is to check if it's safe, with a small…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can the RSV vaccine protect the most vulnerable? new study aims to find out
Disease control Not yet recruitingThis study tests whether the RSV vaccine Abrysvo can help blood cancer patients who have had a stem cell transplant or CAR-T therapy build immunity against RSV. Researchers will measure antibody levels before and after vaccination in 30 adults. The goal is to see if the vaccine t…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Blood test breakthrough could speed up fungal lung infection diagnosis
Diagnosis Not yet recruitingThis study aims to see if a new blood test (mNGS) can accurately diagnose invasive fungal lung infections in 1,000 people with blood disorders. Participants will provide a blood sample and undergo standard tests, then be followed for 42 days. The goal is to find a faster, more re…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Blood test could predict bleeding risk in cancer patients
Knowledge-focused Not yet recruitingThis study aims to create a score that uses a special blood test to predict bleeding risk in people with blood cancers and very low platelet counts. Researchers will take an extra blood sample from 410 participants and analyze it with viscoelastometric tests. The goal is to ident…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Sponsor: Centre Hospitalier Annecy Genevois • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC